State health officials laid out the plan Friday for prioritizing who among Michigan’s 10 million people will get priority for novel coronavirus vaccines, knowing that in the first few weeks and months, supply will be limited.
Michigan is expected to receive 84,825 doses of the COVID-19 vaccine created by Pfizer and its German-based partner BioNTech as soon as it clears the final regulatory hurdle. .
It got closer to that step Friday night, when the U.S. Food and Drug Administration granted Pfizer’s vaccine emergency use authorization. It will now have to be recommended by an advisory committee within the U.S. Centers for Disease Control and Prevention before it can be distributed and injected into the arms of Americans.
“This is great news for our families, front-line workers, small businesses, and economy,” said Gov. Gretchen Whitmer in a statement issued Friday night. “In Michigan, a state built on hard work and innovation, a safe and effective COVID-19 vaccine will be manufactured by Michigan workers at a Michigan business.”